Manipulating gut microbiome may boost efficacy of cancer immunotherapies
The composition of bacteria in the gastrointestinal tract may hold clues to help predict which cancer patients are most apt to benefit from the personalized cellular therapies that have shown unprecedented promise in the fight against hard-to-treat cancers, according to researchers at the Perelman School of Medicine.
FULL STORY AT Penn Medicine News →